{
    "info": {
        "nct_id": "NCT05559164",
        "official_title": "STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy",
        "inclusion_criteria": "* Histologically and/or cytologically confirmed diagnosis of Stage I-III female breast cancer (including inflammatory breast cancer)\n* Scheduled to receive neoadjuvant/adjuvant HER2 targeted therapy\n* Between ≥18 years of age\n* Female patients of childbearing potential must have a negative pregnancy test (serum or urine) prior to enrollment. Female patients must agree to use effective barrier contraception during the period of therapy\n* Baseline LVEF ≥ 50%\n* Prior cancers allowed if no evidence of disease in last 5 years\n* ECOG 0-2\n* No prior history of treatment with HER2 targeted therapy or anthracyclines based chemotherapy\n* Adequate bone marrow function:\n\nI. ANC ≥ 1000/uL II. platelet count ≥ 100,000/uL III. hemoglobin ≥ 9.0 g/dL\n\n• Adequate hepatic function: I. Total bilirubin ≤ 1.5 X ULN II. AST (SGOT) ≤ 5 X ULN III. ALT (SGPT) ≤ 5 X ULN\n\n* Adequate renal function, Creatinine < 1.5x institutional ULN or calculated creatinine clearance ≥ 50 mL/min as estimated using the Cockcroft-Gault formula\n* Ability to understand the nature of this study protocol and give written informed consent\n* Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Participants with stage IV breast cancer\n* Participants currently taking statins\n* Uncontrolled hypertension (systolic blood pressure >190 mm Hg or diastolic blood pressure >100 mm Hg)\n* No active liver disease\n* Current use of CYP 3A4 inhibitors\n* Any condition including the presence of laboratory abnormalities, which, in the opinion of the investigator places the subject at unacceptable risk if he/she were to participate in the study\n* Life expectancy < 12 weeks\n* Pregnancy (positive pregnancy test) or lactation\n* Pre-existing sensory neuropathy > grade one\n* Has significant cardiovascular disease, such as:\n\nLVEF < 50% at baseline as assessed by ECHO (preferred) i) Class III or Class IV myocardial disease as described by the New York Heart Association ii) Recent history (within 6 months prior to enrollment) of myocardial infarction; or iii) Symptomatic arrhythmia at the time of randomization\n\n* Major surgery without complete recovery in the past four weeks prior to screening\n* Concurrent active infection\n* Participant with uncontrolled and/ or active infection with HIV, Hepatitis B or Hepatitis C\n* Participant who has a history of allergy or hypersensitivity to any of the study drugs\n* Participant with a history of interstitial lung disease, history of slowly progressive dyspnea and unproductive cough, sarcoidosis, silicosis, interstitial pulmonary fibrosis, pulmonary hypersensitivity pneumonitis\n* Any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Between ≥18 years of age",
            "criterions": [
                {
                    "exact_snippets": "≥18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior cancers allowed if no evidence of disease in last 5 years",
            "criterions": [
                {
                    "exact_snippets": "Prior cancers allowed if no evidence of disease in last 5 years",
                    "criterion": "prior cancers",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "disease status",
                            "expected_value": "no evidence of disease"
                        },
                        {
                            "requirement_type": "disease-free interval",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate renal function, Creatinine < 1.5x institutional ULN or calculated creatinine clearance ≥ 50 mL/min as estimated using the Cockcroft-Gault formula",
            "criterions": [
                {
                    "exact_snippets": "Adequate renal function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Creatinine < 1.5x institutional ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x institutional ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "calculated creatinine clearance ≥ 50 mL/min as estimated using the Cockcroft-Gault formula",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "mL/min"
                            }
                        },
                        {
                            "requirement_type": "estimation method",
                            "expected_value": "Cockcroft-Gault formula"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand the nature of this study protocol and give written informed consent",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand the nature of this study protocol",
                    "criterion": "ability to understand study protocol",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "give written informed consent",
                    "criterion": "ability to give written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female patients of childbearing potential must have a negative pregnancy test (serum or urine) prior to enrollment. Female patients must agree to use effective barrier contraception during the period of therapy",
            "criterions": [
                {
                    "exact_snippets": "Female patients of childbearing potential must have a negative pregnancy test (serum or urine) prior to enrollment",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "test result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "serum",
                                "urine"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to enrollment"
                        }
                    ]
                },
                {
                    "exact_snippets": "Female patients must agree to use effective barrier contraception during the period of therapy",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "contraception type",
                            "expected_value": "effective barrier"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "during the period of therapy"
                        },
                        {
                            "requirement_type": "agreement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically and/or cytologically confirmed diagnosis of Stage I-III female breast cancer (including inflammatory breast cancer)",
            "criterions": [
                {
                    "exact_snippets": "Histologically and/or cytologically confirmed diagnosis",
                    "criterion": "breast cancer diagnosis confirmation",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Stage I-III female breast cancer",
                    "criterion": "breast cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "female breast cancer",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "including inflammatory breast cancer",
                    "criterion": "inflammatory breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "inclusion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures",
            "criterions": [
                {
                    "exact_snippets": "Willingness ... to comply with scheduled visits",
                    "criterion": "scheduled visits compliance",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willingness ... to comply with ... treatment plans",
                    "criterion": "treatment plan compliance",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willingness ... to comply with ... laboratory tests",
                    "criterion": "laboratory test compliance",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willingness ... to comply with ... other study procedures",
                    "criterion": "other study procedure compliance",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG 0-2",
            "criterions": [
                {
                    "exact_snippets": "ECOG 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Scheduled to receive neoadjuvant/adjuvant HER2 targeted therapy",
            "criterions": [
                {
                    "exact_snippets": "Scheduled to receive neoadjuvant/adjuvant HER2 targeted therapy",
                    "criterion": "HER2 targeted therapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment schedule",
                            "expected_value": [
                                "neoadjuvant",
                                "adjuvant"
                            ]
                        },
                        {
                            "requirement_type": "planned to receive",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "• Adequate hepatic function: I. Total bilirubin ≤ 1.5 X ULN II. AST (SGOT) ≤ 5 X ULN III. ALT (SGPT) ≤ 5 X ULN",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin ≤ 1.5 X ULN",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "AST (SGOT) ≤ 5 X ULN",
                    "criterion": "AST (SGOT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "ALT (SGPT) ≤ 5 X ULN",
                    "criterion": "ALT (SGPT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate bone marrow function:",
            "criterions": [
                {
                    "exact_snippets": "Adequate bone marrow function",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No prior history of treatment with HER2 targeted therapy or anthracyclines based chemotherapy",
            "criterions": [
                {
                    "exact_snippets": "No prior history of treatment with HER2 targeted therapy",
                    "criterion": "prior treatment with HER2 targeted therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "No prior history of treatment with ... anthracyclines based chemotherapy",
                    "criterion": "prior treatment with anthracyclines based chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Baseline LVEF ≥ 50%",
            "criterions": [
                {
                    "exact_snippets": "Baseline LVEF ≥ 50%",
                    "criterion": "left ventricular ejection fraction (LVEF)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "I. ANC ≥ 1000/uL II. platelet count ≥ 100,000/uL III. hemoglobin ≥ 9.0 g/dL",
            "criterions": [
                {
                    "exact_snippets": "ANC ≥ 1000/uL",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "uL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "platelet count ≥ 100,000/uL",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "uL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "hemoglobin ≥ 9.0 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9.0,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Participants with stage IV breast cancer",
            "criterions": [
                {
                    "exact_snippets": "stage IV breast cancer",
                    "criterion": "breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IV"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants currently taking statins",
            "criterions": [
                {
                    "exact_snippets": "Participants currently taking statins",
                    "criterion": "statin use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "LVEF < 50% at baseline as assessed by ECHO (preferred) i) Class III or Class IV myocardial disease as described by the New York Heart Association ii) Recent history (within 6 months prior to enrollment) of myocardial infarction; or iii) Symptomatic arrhythmia at the time of randomization",
            "criterions": [
                {
                    "exact_snippets": "LVEF < 50% at baseline",
                    "criterion": "left ventricular ejection fraction (LVEF)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Class III or Class IV myocardial disease as described by the New York Heart Association",
                    "criterion": "myocardial disease class (NYHA)",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "Class III",
                                "Class IV"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Recent history (within 6 months prior to enrollment) of myocardial infarction",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Symptomatic arrhythmia at the time of randomization",
                    "criterion": "symptomatic arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at the time of randomization"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy < 12 weeks",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy < 12 weeks",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has significant cardiovascular disease, such as:",
            "criterions": [
                {
                    "exact_snippets": "Has significant cardiovascular disease",
                    "criterion": "cardiovascular disease",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No active liver disease",
            "criterions": [
                {
                    "exact_snippets": "No active liver disease",
                    "criterion": "active liver disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled hypertension (systolic blood pressure >190 mm Hg or diastolic blood pressure >100 mm Hg)",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled hypertension (systolic blood pressure >190 mm Hg or diastolic blood pressure >100 mm Hg)",
                    "criterion": "hypertension",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "systolic blood pressure >190 mm Hg",
                    "criterion": "systolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 190,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "diastolic blood pressure >100 mm Hg",
                    "criterion": "diastolic blood pressure",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 100,
                                "unit": "mm Hg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant who has a history of allergy or hypersensitivity to any of the study drugs",
            "criterions": [
                {
                    "exact_snippets": "history of allergy or hypersensitivity to any of the study drugs",
                    "criterion": "allergy or hypersensitivity to study drugs",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pre-existing sensory neuropathy > grade one",
            "criterions": [
                {
                    "exact_snippets": "Pre-existing sensory neuropathy > grade one",
                    "criterion": "sensory neuropathy",
                    "requirements": [
                        {
                            "requirement_type": "pre-existence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "grade"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnancy (positive pregnancy test) or lactation",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy (positive pregnancy test)",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactation",
                    "criterion": "lactation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concurrent active infection",
            "criterions": [
                {
                    "exact_snippets": "Concurrent active infection",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Major surgery without complete recovery in the past four weeks prior to screening",
            "criterions": [
                {
                    "exact_snippets": "Major surgery without complete recovery in the past four weeks prior to screening",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "recovery_status",
                            "expected_value": "not completely recovered"
                        },
                        {
                            "requirement_type": "time_since_surgery",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant with uncontrolled and/ or active infection with HIV, Hepatitis B or Hepatitis C",
            "criterions": [
                {
                    "exact_snippets": "uncontrolled and/ or active infection with HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "uncontrolled",
                                "active"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled and/ or active infection with ... Hepatitis B",
                    "criterion": "Hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "uncontrolled",
                                "active"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled and/ or active infection with ... Hepatitis C",
                    "criterion": "Hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "uncontrolled",
                                "active"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any condition including the presence of laboratory abnormalities, which, in the opinion of the investigator places the subject at unacceptable risk if he/she were to participate in the study",
            "criterions": [
                {
                    "exact_snippets": "Any condition including the presence of laboratory abnormalities, which, in the opinion of the investigator places the subject at unacceptable risk",
                    "criterion": "any condition (including laboratory abnormalities) that places the subject at unacceptable risk",
                    "requirements": [
                        {
                            "requirement_type": "risk assessment",
                            "expected_value": "unacceptable risk as determined by the investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study",
            "criterions": [
                {
                    "exact_snippets": "Any significant medical condition ... that would prevent the subject from participating in the study",
                    "criterion": "significant medical condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "laboratory abnormality ... that would prevent the subject from participating in the study",
                    "criterion": "laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness that would prevent the subject from participating in the study",
                    "criterion": "psychiatric illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant with a history of interstitial lung disease, history of slowly progressive dyspnea and unproductive cough, sarcoidosis, silicosis, interstitial pulmonary fibrosis, pulmonary hypersensitivity pneumonitis",
            "criterions": [
                {
                    "exact_snippets": "history of interstitial lung disease",
                    "criterion": "interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of slowly progressive dyspnea",
                    "criterion": "slowly progressive dyspnea",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of ... unproductive cough",
                    "criterion": "unproductive cough",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sarcoidosis",
                    "criterion": "sarcoidosis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "silicosis",
                    "criterion": "silicosis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "interstitial pulmonary fibrosis",
                    "criterion": "interstitial pulmonary fibrosis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "pulmonary hypersensitivity pneumonitis",
                    "criterion": "pulmonary hypersensitivity pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current use of CYP 3A4 inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Current use of CYP 3A4 inhibitors",
                    "criterion": "CYP 3A4 inhibitor use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}